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Coronavirus spike (S) proteins are responsible for binding and fusion with target cells and thus play an
essential role in virus infection. Recently, we identified a dilysine endoplasmic reticulum (ER) retrieval signal
and a tyrosine-based endocytosis signal in the cytoplasmic tail of the S protein of infectious bronchitis virus
(IBV). Here, an infectious cDNA clone of IBV was used to address the importance of the S protein trafficking
signals to virus infection. We constructed infectious cDNA clones lacking the ER retrieval signal, the endo-
cytosis signal, or both. The virus lacking the ER retrieval signal was viable. However, this virus had a growth
defect at late times postinfection and produced larger plaques than IBV. Further analysis confirmed that the
mutant S protein trafficked though the secretory pathway faster than wild-type S protein. A more dramatic
phenotype was obtained when the endocytosis signal was mutated. Recombinant viruses lacking the endocytosis
signal (in combination with a mutated dilysine signal or alone) could not be recovered, even though transient
syncytia were formed in transfected cells. Our results suggest that the endocytosis signal of IBV S is essential
for productive virus infection.
Assembly and release of virus particles are the final steps of
a virus replication cycle. Therefore, studying virus assembly is
important for understanding viral diseases and controlling in-
fection. Moreover, studying virus assembly is also useful for
understanding the cell biology of protein synthesis and modi-
fication, since viruses depend on cellular machinery for their
replication. Most well-studied enveloped viruses assemble at
the plasma membrane. In these viruses, the membrane-bound
envelope proteins are synthesized at the endoplasmic reticu-
lum (ER) and transported through the cellular secretory path-
way, where they are modified and accumulate on the cell sur-
face for assembly. However, some enveloped viruses (including
flaviviruses, bunyaviruses, and coronaviruses) assemble and
bud into the lumen of the ER, the Golgi complex, or the
ER-Golgi intermediate compartment (ERGIC) (11, 12, 18,
20). Depending on the host cell type, retroviruses can bud into
multivesicular bodies, which are part of the endocytic system
(23). Viruses that assemble intracellularly direct their envelope
proteins to the assembly site by using normal cellular-protein
targeting signals. Virions assembled in intracellular compart-
ments are presumed to exit infected cells by exocytosis.
Coronaviruses have the largest genomes (27 to 31 kb) among
known RNA viruses. Coronaviruses belong to the order
Nidovirales, members of which produce nested sets of sub-
genomic RNAs (sgRNAs) by an unusual discontinuous tran-
scription process (29). Interest in coronaviruses has dramati-
cally increased since the recent emergence of a novel
coronavirus associated with severe acute respiratory syndrome
(SARS) (9, 32). Coronaviruses encode three envelope pro-
teins: small envelope (E), membrane (M), and spike (S). The
E protein is a minor component of the virus envelope; how-
ever, evidence is mounting for the important role of the E
protein in viral budding. E protein interacts with M protein
and coexpression of M and E proteins produces virus-like
particles that are similar to virions in size and shape (2, 3, 5, 22,
34). Elimination of E protein expression in coronaviruses ei-
ther completely blocks virus assembly or produces defective
virions (13, 25). The M protein is the most abundant envelope
protein in virions. M interacts with E, nucleocapsid (N), and S
proteins in mouse hepatitis virus (MHV) and other coronavi-
ruses (2, 21, 24). Both the M and E proteins of infectious
bronchitis virus (IBV) are targeted near the viral assembly site
when expressed independently. The IBV M targeting informa-
tion resides in its first membrane-spanning domain, and that of
IBV E resides in the cytoplasmic tail (3, 17). The coronavirus
S protein is a type I transmembrane protein with a large
ectodomain, a single transmembrane domain, and a short cy-
toplasmic tail (8). S proteins are highly glycosylated, with 21 to
28 predicted N-linked glycosylation sites. In some coronavi-
ruses, full-length S protein (S0) is processed to S1 and S2 by a
furin-like proteinase(s). The S1 domain interacts with cellular
receptors, thus determining the host specificity and tropism.
The S2 domain of S is responsible for fusion of the virus
envelope with the cell membrane and for fusion of infected
cells with neighboring cells late in infection. The S protein is
not essential for production of virus-like particles; however, it
is essential for the production of infectious virus.
MHV S protein expressed alone reaches the cell surface;
however, when coexpressed with the M protein, it is retained
near the virus assembly site (24). We recently found that unlike
the MHV S protein, the IBV S protein is retained near the
virus assembly site when expressed alone (16). In the same
study, we showed that the IBV S protein possesses both a
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dilysine ER retrieval signal and a tyrosine-based endocytosis
signal in its cytoplasmic tail that can modulate trafficking of a
chimeric reporter protein.
In this study, we investigated how the S trafficking signals in
the IBV S cytoplasmic tail affect virus replication during infec-
tion. Using an infectious cDNA clone of IBV, we constructed
mutants lacking the trafficking signals in the S protein. We
show that a recombinant IBV with an S protein lacking the ER
retrieval signal has a growth defect at late times postinfection
(p.i.), which might be the result of faster trafficking of the
mutant S protein through the secretory pathway. Surprisingly,
virus lacking the endocytosis signal (alone or in combination
with a mutated dilysine signal) could not be rescued. We pro-
pose that IBV regulates the level of S at the surface of infected
cells using both of the trafficking signals and that the endocy-
tosis signal plays a major role in virus infection, since it is
essential for productive virus infection.
MATERIALS AND METHODS
Cells, viruses, and antibodies. Vero and baby hamster kidney (BHK-21) cells
were maintained in Dulbecco’s modified Eagle medium (DMEM) containing 5%
fetal bovine serum (FBS) supplemented with penicillin G (100 units/ml) and
streptomycin (100 g/ml). HeLa cells were maintained in DMEM containing
10% FBS and antibiotics. The molecularly cloned Beaudette US strain of IBV
was maintained as described previously (36). The recombinant vaccinia virus
encoding phage T7 RNA polymerase (vTF7-3) has been described previously (6).
The rabbit polyclonal anti-IBV E, anti-IBV M, and anti-IBV S tail antibodies
used for immunoprecipitation were described previously (3, 16, 17). The mouse
monoclonal anti-IBV S antibody (9B1B6) recognizes the luminal domain (35).
The mouse anti-vesicular stomatitis virus glycoprotein (VSV G) monoclonal
antibody used was described previously (15).
Plasmids, mutagenesis, and isolation of recombinant viruses. The S2A and
S4A mutations were introduced into the E amplicon encoding the structural
proteins (36) using the QuikChange site-directed mutagenesis kit (Stratagene,
La Jolla, CA). The codons for lysines in the dilysine ER retrieval signal were
changed to those for alanine, followed by replacement of the tyrosine codons in
the endocytosis signal with these for alanine using primer sets described previ-
ously (16) to create S4A. SYA and S2YA mutations were introduced into the E
amplicon by replacing the codons for one or both tyrosines with those for alanine
using the method described above. After sequencing, the mutated region was
subcloned into the E amplicon to avoid unintentional mutations introduced by
PCR. Amplicons A to E or ES2A, ESY, ES2Y, or ES4A were in vitro ligated, and
the assembled DNAs were used as templates for in vitro transcription of cRNAs
as described previously (36). IBV cRNAs were electroporated with N transcript
at 850 V, 25 F, 950  into BHK-21 cells using an electro-cell manipulator ECM
630 (BTX, San Diego, CA) and cocultured with Vero cells. Transfected cells
were harvested approximately 48 h posttransfection, and recombinant viruses
were amplified in Vero cells and plaque purified three times. Twelve plaque-
purified IBV-S2A clones were sequenced (nucleotides 23540 to 24113) after
reverse transcription-PCR. Two independent IBV and IBV-S2A clones were
amplified and used for further characterization. Since the two clones behaved
identically, the results for one clone for each virus are shown unless otherwise
specified.
One-step growth curve and titration of released and intracellular virus. To
assess growth kinetics, triplicate wells of Vero cells in six-well plates were in-
fected with virus at a multiplicity of infection (MOI) of 2. The total virus
produced was harvested by freezing infected cells every 4 h at 80°C. After three
freeze-thaw cycles, the total virus titer was determined by plaque assay on Vero
cells. The plaques were stained with crystal violet and counted. For comparison
of released and intracellular virus, cells were infected as described above, but the
supernatant and cells were harvested separately at 12 and 16 h postinfection.
Infectious extracellular virus was harvested from supernatants of infected cells
after removing cell debris by centrifugation. Intracellular virus was harvested
from infected cells by adding medium, followed by three freeze-thaw cycles.
Titers of infectious virus from both supernatant and cells (after freeze-thaw)
were determined as described above.
Metabolic labeling, immunoprecipitation, and glycosidase digestion. Vero
cells were infected as described above and, at 7.5 h postinfection, starved for 20
min with methionine- and cysteine-free DMEM at 37°C. The cells were labeled
with 100 Ci of [35S]methionine-cysteine (Promix; Amersham Pharmacia Bio-
tech, Piscataway, NJ) per ml in methionine- and cysteine-free DMEM for 20 min
at 37°C and then chased in unlabeled DMEM containing 5% FBS for various
times as indicated. After a rinse with cold phosphate-buffered saline, the cells
were lysed in NP-40–deoxycholate (DOC) buffer (50 mM Tris-HCl [pH 8.0], 62.5
mM EDTA, 0.5% NP-40, and 0.5% deoxycholate) on ice for 3 min. After
removal of nuclei and cell debris by centrifugation, the lysates were incubated
overnight with 2 l of rabbit anti-IBV E, -IBV M, or -IBV S antibody. Antibody-
antigen complexes were collected by incubation with fixed Staphylococcus aureus
(Pansorbin; Calbiochem, San Diego, CA) for 20 min at room temperature.
Immunoprecipitates were washed three times in low-DOC RIPA buffer (50 mM
Tris-HCl [pH 7.5], 150 mM NaCl, 1% NP-40, 0.5% DOC, and 0.1% sodium
dodecyl sulfate [SDS]) and eluted in 20 l of eluant (50 mM Tris-HCl [pH 6.5]
and 1% SDS) by incubation at 100°C for 3 min. After centrifugation to remove
the immunoadsorbant, an equal volume of 0.15 M sodium citrate (pH 5.5)
containing 0.4 mU of endoglycosidase H (endo H) (New England Biolabs,
Beverly, MA) was added to the samples, and they were incubated overnight at
37°C. The samples were then separated on 10% or 15% SDS-polyacrylamide
gels, and immunoprecipitated proteins were subjected to quantitation on a Mo-
lecular Imager FX phosphorimager (Bio-Rad, Hercules, CA) using Quantity
One software (Bio-Rad).
Coimmunoprecipitation of M with S from infected or transiently transfected
cells. M and S protein interaction was assessed in IBV-infected Vero cells and in
transiently transfected cells. IBV M and S were expressed transiently in cells
infected with a vaccinia virus encoding bacteriophage T7 RNA polymerase using
pAR/IBVM and Bluescript-based S or S4A plasmids described previously (3, 16).
HeLa cells were infected with vTF7-3 at an MOI of 10 in DMEM for 1 h at 37°C,
followed by transfection with a total of 3 g of M and S plasmids (1:5 ratio) using
6 l of TransIT-LT1 (Mirus, Madison, WI) as directed by the manufacturer. At
3 h posttransfection (or 8 h postinfection with IBV), the cells were incubated in
methionine- and cysteine-free MEM for 15 min, labeled for 30 min with methi-
onine-cysteine, and chased for 30 min before the labeled cells were lysed and
immunoprecipitated as described above. To confine the M and S proteins to the
ER, HeLa cells infected and transfected as described above were treated with
brefeldin A (BFA) at a concentration of 1 g/ml during the starvation, labeling,
and chase.
Northern blot analysis. Total cellular RNA of IBV- or IBV-S2A-infected
Vero cells was extracted using TRIZOL reagent (Invitrogen, Palo Alto, CA)
according to the manufacturer’s instructions. Approximately 4 g of total RNA
was electrophoresed on a 1% denaturing agarose gel containing 2.2 M formal-
dehyde. The RNAs were transferred overnight to nylon paper and subjected to
Northern hybridization using a random-primed antisense IBV 3-untranslated-
region probe according to standard methods (27).
Indirect immunofluorescence and antibody uptake. Live-cell antibody uptake
was performed by incubating IBV-infected Vero cells grown on coverslips with
monoclonal anti-IBV S (35) or mouse anti-VSV G (15) as a negative control (0.5
g/ml in culture medium) for 15 min at 37°C. After being washed, the cells were
fixed in 3% paraformaldehyde in phosphate-buffered saline for 10 min at room
temperature and permeabilized with 0.5% Triton X-100 for 3 min. Internal S
protein was labeled using a rabbit antibody that recognizes the cytoplasmic tail
of IBV. Secondary antibodies were Texas red-conjugated goat anti-mouse im-
munoglobulin G (IgG) (Jackson Immunoresearch, PA) and Alexa 488-conju-
gated goat anti-rabbit IgG (Molecular Probes, Eugene, OR). Images were ac-
quired with a Zeiss (Thornwood, NY) Axioscop microscope equipped for
epifluorescence with a Sensys charge-coupled-device camera (Photometrics,
Tucson, AZ), using IPLab software (Scanalytics, Vienna, VA).
RESULTS
Mutation of the IBV S ER retrieval signal in the IBV infec-
tious clone. We previously showed that the cytoplasmic tail of
IBV S protein has two trafficking signals (16). One signal is a
dilysine sequence that retrieves the IBV S protein to the ER
and the other is a tyrosine-based endocytosis signal. A reporter
protein containing the IBV S cytoplasmic tail is retained in the
ERGIC. When the dilysine signal was mutated, the protein was
rapidly transported through the Golgi to the plasma membrane
and then endocytosed. When both the dilysine and endocytosis
signals were mutated, the reporter protein accumulated at the
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plasma membrane. The implications of these data are that IBV
has two mechanisms to prevent accumulation of its S protein at
the cell surface. To address the contribution of the IBV S
protein trafficking signals to IBV infection, an infectious
cDNA clone of IBV described previously (36) was used in this
study. The codons for two lysines in the canonical ER retrieval
signal of the open reading frame (ORF) encoding S in the E
amplicon were replaced with those for alanines by PCR-based
site-directed mutagenesis (Fig. 1, S2A). To avoid unintentional
mutations during PCR-based mutagenesis, a small fragment
containing the mutation was subcloned into the E amplicon
after sequencing.
To investigate the contribution of the IBV S ER retrieval
signal to IBV infection, recombinant IBV-S2A virus was pro-
duced, along with molecularly cloned IBV (referred to here as
IBV) as a control (36). Briefly, in vitro-transcribed cRNA of
IBV or IBV-S2A was transfected, along with in vitro-tran-
scribed IBV N transcript, into BHK-21 cells, and the BHK-21
cells were cocultured with Vero cells. At 20 h posttransfection,
typical IBV cytopathic effects were observed in cells trans-
fected with cRNAs of IBV and IBV-S2A. Both viruses were
harvested at 48 h posttransfection. To further characterize
IBV-S2A, the virus was plaque purified three times, and then
12 independent clones were selected and amplified in Vero
cells. All 12 clones were confirmed to have alanines instead of
lysines at the position of the ER retrieval sequence by reverse
transcription-PCR amplification and sequencing (data not
shown). All experiments were performed with two indepen-
dent clones of IBV and IBV-S2A to avoid complication by
random mutation of recovered recombinant viruses. Because
the two clones of each gave identical results, data from one
clone of each virus (IBV-1 and IBV-S2A-1) are presented
unless otherwise specified.
IBV-S2A has different growth characteristics than IBV.
One-step growth curves for IBV and IBV-S2A were performed
in Vero cells. Cells were infected at an MOI of 2, and the total
virus produced was harvested every 4 hours by freezing cells
and supernatant together. IBV reached a peak titer by 12 h p.i.,
and the titer remained high until 24 h p.i., when it declined
slightly. Recombinant IBV-S2A also reached a peak titer by
12 h p.i. However, after 12 h p.i., virus production rapidly
declined, and at 20 h p.i., total IBV-S2A infectious virus was
10-fold less than that of IBV (Fig. 2).
We also compared the percentage of infectious virus re-
leased from cells infected with IBV and IBV-S2A. For this
experiment, the supernatant and cells were harvested sepa-
rately. At 12 h p.i., 54% of the total infectious IBV was present
in the supernatant, but only 28% of the total infectious IBV-
S2A was released into the supernatant. At 16 h p.i., 59% and
31% of the total infectious IBV and IBV-S2A was present in
the supernatant, respectively (Fig. 3). Thus, IBV-S2A-infected
Vero cells not only produced less total virus but also released
significantly less virus into the supernatant than IBV-infected
Vero cells.
The different growth kinetics of IBV-S2A might be ex-
plained by aberrant or faster trafficking of the S2A protein at
late times in the virus replication cycle. This would result in
lower virus production because of limited S protein at the virus
FIG. 1. Schematic diagram of IBV-S2A, IBV-S2YA, IBV-SYA, and IBV-S4A mutant virus constructs. The upper open boxes represent each
major ORF of the IBV genome, and the closed boxes represent 5 and 3 untranslated regions. The lower boxes represent seven amplicons
encompassing the entire genome of IBV used to construct recombinant IBVs. Amplicon E was used to eliminate the dilysine ER retrieval sequence
located in the C terminus of the IBV S gene by replacing the codons for lysine with those for alanines, producing the S2A amplicon. The S4A
amplicon was constructed using the S2A amplicon by additionally replacing the tyrosine codons for the endocytosis signal with those for alanines.
The SYA and SY2A amplicons were constructed by replacing the single or double tyrosine codons in the endocytosis signal. Seven DNA fragments,
including the E amplicon with or without mutations, were assembled by in vitro ligation and used to transcribe cRNAs. The partial nucleotide
sequence and amino acid sequence of the IBV S C terminus are shown. The trafficking signals are shown in boldface. Lines indicate the same
nucleotide and amino acid sequences as IBV. Asterisks represent stop codons. The underlined sequence represents the core TRS sequence of IBV
subgenomic RNA3.
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assembly site. Interestingly, cell fusion was observed in IBV-
S2A-infected cells at 8 h p.i., whereas IBV-infected cells began
to fuse at 10 h p.i. (data not shown). In subsequent experi-
ments, we repeatedly observed that with identical infection
conditions, IBV-S2A-infected cells formed syncytia earlier
than IBV-infected cells. IBV-S2A also produced slightly bigger
plaques than IBV (Fig. 4). Cell-cell fusion in coronavirus-
infected cells is triggered by the interaction of the S protein on
the infected cell surface with the virus receptors on adjacent
cell surfaces. Therefore, it is likely that the S protein in recom-
binant IBV-S2A traffics more quickly to the cell surface than
wild-type IBV S protein, inducing faster cell fusion and bigger
plaques by increased cell-to-cell infection.
S2A protein is processed in the Golgi more rapidly than
wild-type S protein. Coronavirus S proteins are highly glyco-
sylated proteins; IBV S has 26 predicted N-linked glycosylation
sites. Glycoproteins obtain N-linked oligosaccharides during
their synthesis in the ER, and the oligosaccharides are pro-
cessed as the protein moves though the Golgi stacks. In the
medial Golgi, N-linked oligosaccharides gain resistance to di-
gestion with endo H. The rate at which a glycoprotein moves
through the Golgi can thus be inferred from the rate at which
it acquires endo H resistance. To determine the effect of mu-
tating the ER retrieval signal on IBV S in infected cells, we
compared the processing kinetics of S2A to those of S in a
pulse-chase labeling experiment. Newly synthesized proteins
were labeled with [35S]methionine-cysteine for 20 min at ap-
proximately 8 h p.i., and cells were chased in unlabeled me-
dium for up to 90 min. IBV S and S2A proteins were immu-
noprecipitated from the cell lysates, and immunoprecipitates
were digested with endo H. Differences in oligosaccharide pro-
cessing between S and S2A were observed, with more endo H
resistance acquired by S2A during the chase (Fig. 5A and B).
Oligosaccharide processing of S2A also appeared to be more
extensive than that of S at the chase times analyzed (as shown
FIG. 2. Defective growth of IBV-S2A at late times postinfection.
One-step growth curves of IBV and IBV-S2A were performed. Vero
cells were infected in triplicate with IBV or IBV-S2A at an MOI of 2.
Total virus (supernatant plus cells disrupted by freeze-thaw) was har-
vested at the time points shown. Titers were measured by plaque assay
at each time point. The error bars represent the standard errors of the
means.
FIG. 3. Recombinant IBV-S2A releases less infectious virus than
IBV. Vero cells were infected in triplicate with IBV and IBV-S2A at an
MOI of 2. The percentage of total virus released was determined after
supernatants and cells were harvested separately at 12 and 16 h postin-
fection and titers were determined as described in Materials and Meth-
ods. The percentage of virus released was calculated by dividing the
extracellular virus by the total (intracellular plus extracellular) virus.
The error bars represent the standard errors of the means.
FIG. 4. IBV-S2A produces larger plaques than IBV. (A) Vero cells
were infected with IBV and IBV-S2A and overlaid with medium con-
taining 0.8% agarose for 3 days. The agarose overlay was removed, and
the cells were stained with crystal violet. Plaques produced by IBV are
slightly smaller than plaques produced by IBV-S2A. (B) Average areas
of plaques produced by IBV and IBV-S2A (IBV, n  22; IBV-S2A, n
 30) were measured using Quantity One software (version 4.5.2). The
error bars represent standard deviations. Student’s t test, P  0.00074.
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by the more slowly migrating endo H-resistant species in Fig.
5A). In addition, cleavage of S0 to S1 and S2 was faster for S2A
than for S (Fig. 5A). Interestingly, cleavage of IBV S in in-
fected Vero cells was detected after 20 min of labeling and
preceded oligosaccharide processing. Our results indicate that
IBV S2A traffics through the Golgi faster than wild-type S
protein in virus-infected cells.
The S protein ER retrieval signal appears to overlap with a
critical cis sequence for transcriptional control of subgenomic
RNA3. To complete the characterization of IBV-S2A, we com-
pared the RNA transcription profile of IBV and IBV-S2A by
Northern blotting (Fig. 6A). Surprisingly, we found a signifi-
cant decrease in RNA3 levels (but not the in other subgenomic
RNAs) in IBV-S2A-infected cells compared to those infected
with IBV. The same results were obtained at earlier times p.i.
(8, 10, and 12 h) (data not shown). Subgenomic RNA3 encodes
the 3a, 3b, and E proteins. Since the E protein is thought to be
essential for efficient virus production, we assessed the amount
of E protein produced in infected cells. The reduced RNA3
transcript level in IBV-S2A-infected cells was mirrored by a
reduction in IBV E protein (Fig. 6B). Two independent clones
of IBV-S2A showed reduced levels of E protein compared to
IBV. In contrast to other coronaviruses, most ORFs of IBV
overlap by from 1 to 50 nucleotides. The 3 end of the ORF
encoding the S protein overlaps with the transcriptional regu-
latory sequence (TRS) for RNA3. The mutations in the dil-
ysine signal in IBV S are just downstream of the core TRS (Fig.
1), which could impact the efficiency of the discontinuous tran-
scription process that produces the subgenomic RNAs during
infection (30, 37). Thus, the growth defects of IBV-S2A late in
infection could be the result of the mutation of the ER re-
trieval signal, reduced synthesis of E protein, or both.
Infectious virus cannot be rescued when both targeting sig-
nals in IBV S are mutated. To investigate whether the tyrosine-
based endocytosis signal in IBV S protein further impacts virus
infection, we constructed the IBV-S4A mutant lacking both
the ER retrieval signal and the endocytosis signal (Fig. 1). In
vitro-assembled and -transcribed cRNA of IBV-S4A was elec-
troporated into BHK-21 cells, along with IBV N transcript, as
described above. At 20 h posttransfection, we could detect
several huge syncytia in IBV-S4A-transfected cells (Fig. 7B),
while cells transfected with IBV cRNA started to show only
small syncytia at the same time point (Fig. 7A). Around 30 h
posttransfection, cells transfected with IBV cRNA showed
more and larger syncytia (not shown). At the same time point,
the huge syncytia seen in cells transfected with IBV-S4A
FIG. 5. S2A protein traffics through the Golgi faster than wild-type
IBV S protein in infected cells. (A) At 8 h p.i., Vero cells infected with
IBV and IBV-S2A were pulse-labeled with [35S]methionine-cysteine
for 20 min and chased for the times indicated. Lysates were immuno-
precipitated with anti-IBV S antibody and treated with endo H prior to
sodium dodecyl sulfate-polyacrylamide gel electrophoresis. The arrow-
head indicates endo H-sensitive uncleaved S0 protein, the bracket
indicates the heterogeneous population of endo H-resistant cleaved
S1/S2, and the asterisk indicates endo H-sensitive S1/S2. C, uninfected
Vero cells; S, IBV-infected Vero cells; S2A, IBV-S2A-infected Vero
cells. (B) The percentage of endo H-resistant S was calculated by
dividing the amount of resistant S1/S2 by the total S for each time point.
These data are representative of three independent experiments.
FIG. 6. Mutation of the dilysine signal in IBV S affects transcrip-
tion and translation of the downstream ORF. (A) At 24 h p.i., total
cellular RNAs from wild-type IBV- or IBV-S2A-infected Vero cells
were extracted and subjected to Northern blotting for subgenomic
RNA profile analysis as described in Materials and Methods. Tran-
scription of RNA3 (but not the other subgenomic RNAs) was signif-
icantly decreased in IBV-S2A-infected cells compared to that in cells
infected with IBV. (B) E protein levels were analyzed by immunopre-
cipitation from [35S]methionine-cysteine-labeled infected Vero cells.
At 9.5 h p.i., IBV- or IBV-S2A-infected Vero cells were labeled for 30
min and lysed, and the lysates were split in two and immunoprecipi-
tated with anti-IBV E or anti-IBV M antibody. The results for two
different clones of IBV-S2A (1 and 4) are shown.
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cRNA rounded up and detached from the plate (Fig. 7C).
Healthy-looking Vero cells replaced the empty area created by
detachment of the huge syncytia. At 48 h postinfection, IBV-
transfected cells showed extensive cell death caused by the
viral infection while IBV-S4A-transfected cells were over-
grown. We passaged IBV-S4A-transfected cell lysates twice;
however, we never observed any virus-induced cytopathic ef-
fects. We repeated this experiment four times, and the same
results (production of huge syncytia followed by their disap-
pearance) were obtained in all cases. Thus, mutation of both
targeting signals in the cytoplasmic tail of IBV S was incom-
patible with recovery of infectious virus.
The S4A mutation does not disrupt S-M interaction. The
IBV-S4A protein has four amino acid substitutions in its cyto-
plasmic tail. The cytoplasmic tail of MHV S has been shown to
interact with MHV M protein (24). Thus, one explanation for
failure to produce recombinant IBV with the S4A mutation is
disruption of the interaction between IBV S and IBV M. This
possibility was investigated using methods similar to those de-
scribed for MHV (24). First, to confirm interaction of the IBV
M and S proteins, IBV-infected Vero cells were labeled with
[35S]methionine-cysteine and chased for 30 min at 8 h p.i. The
cells were lysed and immunoprecipitated with an antibody
against IBV M. As shown in Fig. 8A, IBV S could be coim-
munoprecipitated with anti-M antibody even in the absence of
cross-linking. Our antibody against the cytoplasmic tail of IBV
S did not coimmunoprecipitate M protein as efficiently as an-
tibody against M coimmunoprecipitated S, perhaps because
antibody binding to the S tail disrupted interaction with M.
Next, interaction of the S4A protein with IBV M was tested.
We transiently expressed IBV M with wild-type IBV S or S4A
using a vaccinia virus T7 expression system. Transfected cells
were labeled with [35S]methionine-cysteine for 30 min and
chased for 30 min. Interaction was assessed by coimmunopre-
cipitation of S protein with anti-IBV M antibody. Compared to
wild-type S, S4A protein interacted with M less efficiently (Fig.
8B). However, this transient-expression system does not repro-
duce the same timing of protein production as in infected cells.
The faster trafficking of S4A protein in this transient system
could result in an insufficient amount of time to interact with M
protein, which is retained in the Golgi region. To determine if
the inefficient interaction of S4A and M was due to a genuine
defect in the interaction between these proteins or due to the
increased trafficking rate of S4A protein, BFA was used. BFA
causes the Golgi complex to collapse into the ER and thus
blocks export of proteins from the ER (10). By confining M
and S proteins to the ER with BFA treatment, interaction of M
and S4A protein comparable to that of M and wild-type S
protein was observed (Fig. 8B). Based on these results, it is
unlikely that defective interaction of S4A with IBV M explains
the inability to rescue IBV-S4A.
Infectious virus cannot be rescued when only the tyrosine-
based endocytosis signal is mutated. IBV-S4A could not be
rescued, even though huge syncytia formed in transfected cells
and the S4A protein could interact with IBV M as well as
wild-type S protein. We previously showed that the endocytosis
signal restricts the amount of IBV S protein on the cell surface,
even though the signal itself does not influence trafficking of
the S protein from the ER through the Golgi (16). To test the
possibility that the endocytosis signal plays an important role in
virus replication, we constructed a mutant lacking the two
tyrosines in the YYTF endocytosis signal (S2YA) (Fig. 1). To
our surprise, we were unable to rescue IBV-S2YA even though
we could detect transient, normal-size syncytia approximately
FIG. 7. Large transient syncytia formed after electroporation of
cRNA with the S4A mutation, but no infectious virus could be recov-
ered. In vitro-transcribed IBV or IBV-S4A cRNAs were electropo-
rated into BHK-21 cells, which were then cocultured with Vero cells.
(A) At 20 h posttransfection, normal-size syncytia started to form in
IBV cRNA-transfected cells. (B) At 20 h posttransfection of IBV-S4A
cRNA, transfected cells showed far fewer but much larger syncytia
than IBV cRNA-transfected cells. (C) At 30 h posttransfection of
IBV-S4A cRNA, the giant syncytia started to disappear by clumping
and detaching from the dish. Uninfected Vero cells expanded to fill the
empty areas left by the syncytia. Bars, 100 m.
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30 h posttransfection (data not shown). These syncytia re-
solved similarly to those in cells transfected with IBV-S4A
cRNA, except that they lasted longer, until approximately 48 h
posttransfection. We further constructed a mutant (IBV-SYA)
where only the key tyrosine was changed to alanine (Fig. 1).
We were unable to rescue the IBV-SYA mutant as well. The
latter mutation changed only 2 nucleotides at a site 25 nucle-
otides upstream of the core TRS for subgenomic RNA3. We
believe it is unlikely that the tyrosine-to-alanine mutation in-
terferes with transcription of RNA3, although we could not
test this directly because recombinant virus could not be re-
covered. Thus, we favor the idea that the tyrosine-based en-
docytosis signal plays an essential role in virus infection.
IBV S is endocytosed from the surfaces of infected cells. Our
results suggested that endocytosis of IBV S plays a critical role
in infection. To obtain direct evidence that IBV S is endocy-
tosed in infected cells, we followed trafficking of the protein
using exogenously added antibodies. After 15 min at 37°C, the
anti-IBV S monoclonal antibody added to the culture medium
was internalized into endosome-like puncta, whereas none of a
control monoclonal antibody was endocytosed (Fig. 9). Only
cells with the highest levels of S expression internalized the
antibodies, consistent with the idea that S protein does not
reach the plasma membrane until the ER retrieval machinery
is saturated. These results suggest that once the IBV S protein
reaches the plasma membrane it is rapidly endocytosed.
DISCUSSION
Contribution of the S protein ER retrieval signal to IBV
infection. We previously showed that the IBV S protein con-
tains two intracellular trafficking signals in its cytoplasmic tail:
a dilysine ER retrieval signal and a tyrosine-based endocytosis
signal (16). The purpose of this study was to evaluate the
contribution of the IBV S protein trafficking signals to virus
infection. First, we constructed a recombinant IBV lacking the
ER retrieval signal in the S protein. After in vitro assembly and
in vitro transcription, followed by transfection of full-length
IBV-S2A cRNA, recombinant virus was rescued. IBV-S2A had
a growth defect at late times p.i., with a titer 10-fold lower than
that of IBV. In infected cells, the S2A protein behaved simi-
larly to the chimeric protein lacking the dilysine signal (16).
First, a pulse-chase experiment confirmed that S2A traffics
through the Golgi complex faster than wild-type S. Second, we
could repeatedly detect earlier syncytium formation in IBV-
S2A-infected cells than in cells infected with wild-type virus.
Third, IBV-S2A virus produced larger plaques than the wild-
type virus. These last two results can be explained by faster
trafficking of the S protein to the infected cell surface, thus
causing earlier induction of cell-to-cell fusion between the in-
fected cells and neighboring cells. Clearly, the ER retrieval
signal in IBV S protein is used in virus infection. The other
phenotype of IBV-S2A was a reduced efficiency of release of
infectious virus, which was unexpected. Perhaps earlier forma-
tion of syncytia induced by faster trafficking of S2A hinders
release of virus.
When analyzing subgenomic RNA production by Northern
blotting, we made the surprising observation that RNA3 levels
were decreased in cells infected with IBV-S2A compared to
those infected with IBV. The decrease in RNA3 levels was
mirrored by reduced levels of IBV E protein in IBV-S2A-
infected cells. Thus, we could not rule out the possibility that
the growth defect at late times p.i. was the result of decreased
production of E protein. Coronaviruses produce their sgRNAs
by a process of discontinuous transcription, producing a nested
set of sgRNAs that share the same 5 leader sequence. Base
pairing between the leader sequence and the TRS that pre-
cedes each ORF is essential for sgRNA production (33, 37). In
contrast to other coronaviruses, most IBV ORFs overlap each
other, and the core TRS for RNA3 is just upstream of the
sequence that encodes the dilysine signal in the S tail (Fig. 1).
We speculate that the mutations in S2A affect the discontinu-
ous transcription process leading to production of RNA3. Se-
quences flanking the core TRS, particularly those downstream,
have been shown to affect sgRNA production in transmissible
gastroenteritis virus (30). This region may be important for
transcription of RNA3 in IBV, since the core TRS sequence
FIG. 8. IBV-S4A interacts normally with IBV M. Interaction of S
or S4A with IBV M protein was assessed by coimmunoprecipitation.
(A) IBV S and M proteins interact in IBV-infected Vero cells. At 8 h
p.i., Vero cells infected with IBV were labeled with [35S]methionine-
cysteine for 30 min, and the cell lysate was subjected to immunopre-
cipitation with anti-IBV M or anti-IBV S antibody. (B) S or S4A
protein was coexpressed with IBV M protein transiently using vaccinia
virus expressing T7 RNA polymerase. After a 30-min pulse-labeling
and 30-min chase in the presence or absence of BFA, S or S4A was
coimmunoprecipitated with anti-IBV M antibody.
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for RNA3 contains a 1-nucleotide mismatch with the leader
TRS core. Further study will be required to determine whether
the growth defect in IBV-S2A is due solely to the mutation’s
effect on RNA3 synthesis or if the dilysine signal itself plays an
important role in IBV infection.
Contribution of the endocytosis signal in the IBV S cyto-
plasmic tail to virus infection. Compared to mutation of the
dilysine signal, mutation of the endocytosis signal gave a more
dramatic phenotype. Infectious virus could not be recovered
even when as few as 2 nucleotides were mutated to change the
key tyrosine residue. The mutations of both trafficking signals
in the S tail did not block interaction with M; therefore, de-
creased interaction of S and M is unlikely to explain the failure
to recover IBV lacking the tyrosine endocytosis signal. Al-
though we cannot rule out the possibility that the mutation
affects RNA3 production or virus replication, we favor the idea
that endocytosis of IBV S is essential to productive virus in-
fection. It follows that the dilysine signal in IBV S plays a less
important role in virus infection than the endocytosis signal.
This idea is supported by the observation that the endocytosis
signal is conserved in all IBV strains while the dilysine signal is
absent in several due to a stop codon that truncates the S
protein. Why would the IBV S protein need an endocytosis
signal if it contains a dilysine ER retrieval signal? Even though
the dilysine signal is effective at retaining the protein in the
ERGIC at low expression levels, it is likely that the ER re-
trieval machinery is easily saturated. We found this to be true
using transient expression of chimeric proteins containing the
IBV S tail (16). At late times p.i., when S expression levels are
high, it is likely that S escapes to the cell surface, where it can
induce cell-cell fusion. We originally hypothesized that the
targeting information in IBV S helps to localize the protein to
the virus assembly site. However, the data presented here
suggest that the IBV S trafficking signals may be more impor-
tant in regulating the level of IBV S at the cell surface. Syncytia
undergo significant internal membrane rearrangements (14),
and the distance from the site of virus assembly to the plasma
membrane is significantly increased. The production of large
syncytia could thus interfere with virus budding or release.
Tyrosine-based sorting signals and implications for the
coronavirus replication cycle. The type of endocytic signal
assessed here in the IBV S protein (YXX, where X is any
amino acid and  is a bulky hydrophobic residue) has been
shown to mediate other sorting events for membrane proteins
in addition to endocytosis. This motif can target proteins from
the trans-Golgi network directly to endosomes/lysosomes and
to the basolateral plasma membrane in polarized epithelial
cells (1). Here, we were able to directly demonstrate that IBV
S was rapidly endocytosed from the plasma membranes of
infected cells. Thus, we favor the interpretation that the YXX
sequence in IBV functions as a canonical endocytosis signal.
Interestingly, lentivirus Env proteins all contain conserved
endocytosis signals (4, 26, 28, 31), and in the case of simian
immunodeficiency virus, mutation of the endocytosis signal
FIG. 9. IBV S is rapidly endocytosed in infected cells. Vero cells on coverslips were infected with IBV at a MOI of 0.1 for approximately 18 h.
A monoclonal antibody against the IBV S ectodomain (or the VSV G ectodomain as a negative control) was added to the culture medium for 15
min at 37°C. After being thoroughly washed, the cells were fixed, permeabilized, and stained for internal S protein using a rabbit antibody to the
S cytoplasmic tail. Exogenously added monoclonal antibodies were detected using Texas red-conjugated goat anti-mouse IgG, and the internal
antibody staining was detected with Alexa 488-conjugated goat anti-rabbit IgG. The left panels show internalized antibody, and the right panels
show the internal staining of the same field. Note that only the cell with the higher intracellular level of IBV S endocytosed detectable antibody.
13216 YOUN ET AL. J. VIROL.
 o
n
 Septem
ber 12, 2018 by guest
http://jvi.asm.org/
D
ow
nloaded from
 
significantly attenuates infection in vivo (7). Perhaps a com-
mon strategy for enveloped viruses that encode fusion proteins
that fuse at neutral pH is to regulate the surface levels of these
proteins by using endocytosis. Indeed, there is a growing ap-
preciation of the potential role of endocytosis in multiple
stages of virus replication cycles (19). Interestingly, the S pro-
teins of group 1 and 3 coronaviruses possess both ER retrieval
signals (16) and predicted endocytosis signals in their cytoplas-
mic domains. SARS S contains a dibasic ER retrieval signal but
lacks a predicted endocytosis signal. Group 2 coronaviruses
lack both ER retrieval and predicted endocytosis signals. The
possibility exists for a novel endocytosis signal in the S proteins
from group 2 coronaviruses and SARS. We will continue to
explore the requirement for endocytosis of IBV S by introduc-
ing endocytosis signals in new places in the cytoplasmic tail of
IBV using the infectious clone.
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